nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—ABCB1—peripheral nervous system neoplasm	0.384	1	CbGaD
Naloxone—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0574	0.173	CbGbCtD
Naloxone—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0418	0.126	CbGbCtD
Naloxone—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0418	0.126	CbGbCtD
Naloxone—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.029	0.0874	CbGbCtD
Naloxone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.025	0.0755	CbGbCtD
Naloxone—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0241	0.0728	CbGbCtD
Naloxone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0233	0.0702	CbGbCtD
Naloxone—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0178	0.0538	CbGbCtD
Naloxone—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0166	0.0502	CbGbCtD
Naloxone—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0163	0.0493	CbGbCtD
Naloxone—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0111	0.0336	CbGbCtD
Naloxone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0107	0.0322	CbGbCtD
Naloxone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00979	0.0295	CbGbCtD
Naloxone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00668	0.0201	CbGbCtD
Naloxone—CREB1—nerve—peripheral nervous system neoplasm	0.00239	0.159	CbGeAlD
Naloxone—CREB1—ganglion—peripheral nervous system neoplasm	0.00236	0.157	CbGeAlD
Naloxone—OPRD1—ganglion—peripheral nervous system neoplasm	0.00187	0.124	CbGeAlD
Naloxone—OPRM1—nerve—peripheral nervous system neoplasm	0.00129	0.0856	CbGeAlD
Naloxone—OPRM1—ganglion—peripheral nervous system neoplasm	0.00127	0.0845	CbGeAlD
Naloxone—CREB1—trigeminal ganglion—peripheral nervous system neoplasm	0.00116	0.077	CbGeAlD
Naloxone—TLR4—cerebellum—peripheral nervous system neoplasm	0.00115	0.0763	CbGeAlD
Naloxone—CREB1—brainstem—peripheral nervous system neoplasm	0.00103	0.0682	CbGeAlD
Naloxone—Flushing—Melphalan—peripheral nervous system neoplasm	0.000687	0.00471	CcSEcCtD
Naloxone—Angiopathy—Topotecan—peripheral nervous system neoplasm	0.000686	0.00471	CcSEcCtD
Naloxone—Mediastinal disorder—Topotecan—peripheral nervous system neoplasm	0.000682	0.00467	CcSEcCtD
Naloxone—Angiopathy—Tretinoin—peripheral nervous system neoplasm	0.000681	0.00467	CcSEcCtD
Naloxone—Angiopathy—Isotretinoin—peripheral nervous system neoplasm	0.000681	0.00467	CcSEcCtD
Naloxone—Chills—Topotecan—peripheral nervous system neoplasm	0.000679	0.00465	CcSEcCtD
Naloxone—Chills—Tretinoin—peripheral nervous system neoplasm	0.000673	0.00462	CcSEcCtD
Naloxone—Chills—Isotretinoin—peripheral nervous system neoplasm	0.000673	0.00462	CcSEcCtD
Naloxone—Irritability—Cisplatin—peripheral nervous system neoplasm	0.000668	0.00458	CcSEcCtD
Naloxone—Mediastinal disorder—Melphalan—peripheral nervous system neoplasm	0.000667	0.00458	CcSEcCtD
Naloxone—Mental disorder—Isotretinoin—peripheral nervous system neoplasm	0.000657	0.00451	CcSEcCtD
Naloxone—Mental disorder—Tretinoin—peripheral nervous system neoplasm	0.000657	0.00451	CcSEcCtD
Naloxone—Tension—Tretinoin—peripheral nervous system neoplasm	0.000641	0.00439	CcSEcCtD
Naloxone—Tension—Isotretinoin—peripheral nervous system neoplasm	0.000641	0.00439	CcSEcCtD
Naloxone—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.000634	0.00435	CcSEcCtD
Naloxone—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.000634	0.00435	CcSEcCtD
Naloxone—Depression—Alitretinoin—peripheral nervous system neoplasm	0.000632	0.00433	CcSEcCtD
Naloxone—Nasopharyngitis—Cisplatin—peripheral nervous system neoplasm	0.000626	0.00429	CcSEcCtD
Naloxone—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.000612	0.0042	CcSEcCtD
Naloxone—Tremor—Tretinoin—peripheral nervous system neoplasm	0.000612	0.0042	CcSEcCtD
Naloxone—Cardiac arrest—Etoposide—peripheral nervous system neoplasm	0.00061	0.00418	CcSEcCtD
Naloxone—Depression—Vincristine—peripheral nervous system neoplasm	0.000609	0.00417	CcSEcCtD
Naloxone—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.000607	0.00416	CcSEcCtD
Naloxone—Agitation—Tretinoin—peripheral nervous system neoplasm	0.0006	0.00412	CcSEcCtD
Naloxone—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.0006	0.00412	CcSEcCtD
Naloxone—Sweating—Vincristine—peripheral nervous system neoplasm	0.000585	0.00401	CcSEcCtD
Naloxone—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.000569	0.0039	CcSEcCtD
Naloxone—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.000566	0.00388	CcSEcCtD
Naloxone—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.000566	0.00388	CcSEcCtD
Naloxone—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.000566	0.00388	CcSEcCtD
Naloxone—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.000564	0.00387	CcSEcCtD
Naloxone—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.000564	0.00387	CcSEcCtD
Naloxone—Convulsion—Melphalan—peripheral nervous system neoplasm	0.000559	0.00383	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000557	0.00382	CcSEcCtD
Naloxone—OPRM1—brainstem—peripheral nervous system neoplasm	0.000553	0.0367	CbGeAlD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000552	0.00379	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000552	0.00379	CcSEcCtD
Naloxone—Chills—Dactinomycin—peripheral nervous system neoplasm	0.00055	0.00377	CcSEcCtD
Naloxone—Hallucination—Vincristine—peripheral nervous system neoplasm	0.000545	0.00374	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000545	0.00374	CcSEcCtD
Naloxone—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.000528	0.00362	CcSEcCtD
Naloxone—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000527	0.00361	CcSEcCtD
Naloxone—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000523	0.00358	CcSEcCtD
Naloxone—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000523	0.00358	CcSEcCtD
Naloxone—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000522	0.00358	CcSEcCtD
Naloxone—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00052	0.00357	CcSEcCtD
Naloxone—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00052	0.00357	CcSEcCtD
Naloxone—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00052	0.00356	CcSEcCtD
Naloxone—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000518	0.00355	CcSEcCtD
Naloxone—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000518	0.00355	CcSEcCtD
Naloxone—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.000516	0.00354	CcSEcCtD
Naloxone—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000515	0.00353	CcSEcCtD
Naloxone—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000515	0.00353	CcSEcCtD
Naloxone—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000514	0.00352	CcSEcCtD
Naloxone—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000511	0.0035	CcSEcCtD
Naloxone—Chills—Alitretinoin—peripheral nervous system neoplasm	0.00051	0.0035	CcSEcCtD
Naloxone—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.000509	0.00349	CcSEcCtD
Naloxone—CREB1—cerebellum—peripheral nervous system neoplasm	0.000506	0.0336	CbGeAlD
Naloxone—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.000498	0.00342	CcSEcCtD
Naloxone—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.000497	0.00341	CcSEcCtD
Naloxone—Ventricular tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000496	0.0034	CcSEcCtD
Naloxone—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.000494	0.00339	CcSEcCtD
Naloxone—Injection site reaction—Epirubicin—peripheral nervous system neoplasm	0.000493	0.00338	CcSEcCtD
Naloxone—Tension—Alitretinoin—peripheral nervous system neoplasm	0.000486	0.00333	CcSEcCtD
Naloxone—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.000483	0.00331	CcSEcCtD
Naloxone—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.000481	0.0033	CcSEcCtD
Naloxone—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.00048	0.00329	CcSEcCtD
Naloxone—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000479	0.00329	CcSEcCtD
Naloxone—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000479	0.00328	CcSEcCtD
Naloxone—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000479	0.00328	CcSEcCtD
Naloxone—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000475	0.00326	CcSEcCtD
Naloxone—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000475	0.00326	CcSEcCtD
Naloxone—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000472	0.00324	CcSEcCtD
Naloxone—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000469	0.00322	CcSEcCtD
Naloxone—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000464	0.00318	CcSEcCtD
Naloxone—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000464	0.00318	CcSEcCtD
Naloxone—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00046	0.00316	CcSEcCtD
Naloxone—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00046	0.00316	CcSEcCtD
Naloxone—Pain—Topotecan—peripheral nervous system neoplasm	0.00046	0.00315	CcSEcCtD
Naloxone—Ventricular tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.00314	CcSEcCtD
Naloxone—Pain—Tretinoin—peripheral nervous system neoplasm	0.000456	0.00313	CcSEcCtD
Naloxone—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000456	0.00313	CcSEcCtD
Naloxone—Injection site reaction—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.00312	CcSEcCtD
Naloxone—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000455	0.00312	CcSEcCtD
Naloxone—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000454	0.00311	CcSEcCtD
Naloxone—Coma—Epirubicin—peripheral nervous system neoplasm	0.000453	0.0031	CcSEcCtD
Naloxone—Pain—Melphalan—peripheral nervous system neoplasm	0.00045	0.00309	CcSEcCtD
Naloxone—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00045	0.00308	CcSEcCtD
Naloxone—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00045	0.00308	CcSEcCtD
Naloxone—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.000441	0.00302	CcSEcCtD
Naloxone—Agitation—Vincristine—peripheral nervous system neoplasm	0.000438	0.00301	CcSEcCtD
Naloxone—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000437	0.00299	CcSEcCtD
Naloxone—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000429	0.00294	CcSEcCtD
Naloxone—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000427	0.00293	CcSEcCtD
Naloxone—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000425	0.00291	CcSEcCtD
Naloxone—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000425	0.00291	CcSEcCtD
Naloxone—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000421	0.00289	CcSEcCtD
Naloxone—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000421	0.00289	CcSEcCtD
Naloxone—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000421	0.00289	CcSEcCtD
Naloxone—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000421	0.00289	CcSEcCtD
Naloxone—Coma—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.00287	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000419	0.00287	CcSEcCtD
Naloxone—Naltrexone—ABCB1—peripheral nervous system neoplasm	0.000416	0.425	CrCbGaD
Naloxone—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000413	0.00283	CcSEcCtD
Naloxone—Flushing—Etoposide—peripheral nervous system neoplasm	0.000412	0.00282	CcSEcCtD
Naloxone—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000412	0.00282	CcSEcCtD
Naloxone—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000412	0.00282	CcSEcCtD
Naloxone—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.0028	CcSEcCtD
Naloxone—ESR1—brainstem—peripheral nervous system neoplasm	0.000404	0.0268	CbGeAlD
Naloxone—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000403	0.00276	CcSEcCtD
Naloxone—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.0004	0.00274	CcSEcCtD
Naloxone—Chills—Etoposide—peripheral nervous system neoplasm	0.000398	0.00273	CcSEcCtD
Naloxone—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000396	0.00272	CcSEcCtD
Naloxone—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000395	0.00271	CcSEcCtD
Naloxone—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000394	0.0027	CcSEcCtD
Naloxone—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000392	0.00269	CcSEcCtD
Naloxone—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000391	0.00268	CcSEcCtD
Naloxone—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000386	0.00264	CcSEcCtD
Naloxone—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.000384	0.00264	CcSEcCtD
Naloxone—OPRK1—cerebellum—peripheral nervous system neoplasm	0.000383	0.0255	CbGeAlD
Naloxone—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000382	0.00262	CcSEcCtD
Naloxone—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000382	0.00262	CcSEcCtD
Naloxone—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000382	0.00262	CcSEcCtD
Naloxone—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.000381	0.00261	CcSEcCtD
Naloxone—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000378	0.00259	CcSEcCtD
Naloxone—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000376	0.00258	CcSEcCtD
Naloxone—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000373	0.00255	CcSEcCtD
Naloxone—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000368	0.00252	CcSEcCtD
Naloxone—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000365	0.00251	CcSEcCtD
Naloxone—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000365	0.0025	CcSEcCtD
Naloxone—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000365	0.0025	CcSEcCtD
Naloxone—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000363	0.00249	CcSEcCtD
Naloxone—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00036	0.00247	CcSEcCtD
Naloxone—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00036	0.00247	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000357	0.00245	CcSEcCtD
Naloxone—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.00244	CcSEcCtD
Naloxone—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.00242	CcSEcCtD
Naloxone—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00035	0.0024	CcSEcCtD
Naloxone—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000349	0.00239	CcSEcCtD
Naloxone—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000345	0.00237	CcSEcCtD
Naloxone—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000344	0.00236	CcSEcCtD
Naloxone—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000344	0.00236	CcSEcCtD
Naloxone—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000342	0.00234	CcSEcCtD
Naloxone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000342	0.00234	CcSEcCtD
Naloxone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000339	0.00232	CcSEcCtD
Naloxone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000339	0.00232	CcSEcCtD
Naloxone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000338	0.00231	CcSEcCtD
Naloxone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000336	0.0023	CcSEcCtD
Naloxone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000336	0.0023	CcSEcCtD
Naloxone—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000335	0.0023	CcSEcCtD
Naloxone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000335	0.00229	CcSEcCtD
Naloxone—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000334	0.00229	CcSEcCtD
Naloxone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000334	0.00229	CcSEcCtD
Naloxone—Pain—Vincristine—peripheral nervous system neoplasm	0.000333	0.00228	CcSEcCtD
Naloxone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000333	0.00228	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000327	0.00224	CcSEcCtD
Naloxone—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000322	0.00221	CcSEcCtD
Naloxone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000319	0.00219	CcSEcCtD
Naloxone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000319	0.00219	CcSEcCtD
Naloxone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000319	0.00219	CcSEcCtD
Naloxone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000317	0.00217	CcSEcCtD
Naloxone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000317	0.00217	CcSEcCtD
Naloxone—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.00217	CcSEcCtD
Naloxone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000313	0.00214	CcSEcCtD
Naloxone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000313	0.00214	CcSEcCtD
Naloxone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000309	0.00212	CcSEcCtD
Naloxone—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000308	0.00211	CcSEcCtD
Naloxone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000308	0.00211	CcSEcCtD
Naloxone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000308	0.00211	CcSEcCtD
Naloxone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000307	0.0021	CcSEcCtD
Naloxone—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000306	0.0021	CcSEcCtD
Naloxone—Buprenorphine—ABCB1—peripheral nervous system neoplasm	0.000305	0.313	CrCbGaD
Naloxone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000305	0.00209	CcSEcCtD
Naloxone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000298	0.00204	CcSEcCtD
Naloxone—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.00204	CcSEcCtD
Naloxone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000297	0.00204	CcSEcCtD
Naloxone—Pain—Cisplatin—peripheral nervous system neoplasm	0.000294	0.00202	CcSEcCtD
Naloxone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.00199	CcSEcCtD
Naloxone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000283	0.00194	CcSEcCtD
Naloxone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000281	0.00193	CcSEcCtD
Naloxone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000279	0.00192	CcSEcCtD
Naloxone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000277	0.0019	CcSEcCtD
Naloxone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000276	0.0019	CcSEcCtD
Naloxone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000272	0.00187	CcSEcCtD
Naloxone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000272	0.00187	CcSEcCtD
Naloxone—Pain—Etoposide—peripheral nervous system neoplasm	0.00027	0.00185	CcSEcCtD
Naloxone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000266	0.00183	CcSEcCtD
Naloxone—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000266	0.00182	CcSEcCtD
Naloxone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000259	0.00177	CcSEcCtD
Naloxone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000257	0.00176	CcSEcCtD
Naloxone—Morphine—ABCB1—peripheral nervous system neoplasm	0.000256	0.262	CrCbGaD
Naloxone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000249	0.00171	CcSEcCtD
Naloxone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000249	0.00171	CcSEcCtD
Naloxone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000248	0.0017	CcSEcCtD
Naloxone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000247	0.00169	CcSEcCtD
Naloxone—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.00169	CcSEcCtD
Naloxone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.00165	CcSEcCtD
Naloxone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000236	0.00161	CcSEcCtD
Naloxone—SLCO1A2—cerebellum—peripheral nervous system neoplasm	0.000235	0.0156	CbGeAlD
Naloxone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000231	0.00159	CcSEcCtD
Naloxone—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000231	0.00158	CcSEcCtD
Naloxone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000231	0.00158	CcSEcCtD
Naloxone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000226	0.00155	CcSEcCtD
Naloxone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000226	0.00155	CcSEcCtD
Naloxone—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000224	0.00154	CcSEcCtD
Naloxone—Chills—Epirubicin—peripheral nervous system neoplasm	0.000223	0.00153	CcSEcCtD
Naloxone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000219	0.0015	CcSEcCtD
Naloxone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000218	0.00149	CcSEcCtD
Naloxone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000216	0.00148	CcSEcCtD
Naloxone—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.00147	CcSEcCtD
Naloxone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.00147	CcSEcCtD
Naloxone—Tension—Epirubicin—peripheral nervous system neoplasm	0.000213	0.00146	CcSEcCtD
Naloxone—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00021	0.00144	CcSEcCtD
Naloxone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.00143	CcSEcCtD
Naloxone—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.00142	CcSEcCtD
Naloxone—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.00142	CcSEcCtD
Naloxone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000204	0.0014	CcSEcCtD
Naloxone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.00138	CcSEcCtD
Naloxone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000201	0.00137	CcSEcCtD
Naloxone—ESR1—cerebellum—peripheral nervous system neoplasm	0.000199	0.0132	CbGeAlD
Naloxone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000199	0.00136	CcSEcCtD
Naloxone—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.00135	CcSEcCtD
Naloxone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.00133	CcSEcCtD
Naloxone—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000188	0.00129	CcSEcCtD
Naloxone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000187	0.00128	CcSEcCtD
Naloxone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000187	0.00128	CcSEcCtD
Naloxone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.00126	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00126	CcSEcCtD
Naloxone—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.00018	0.012	CbGeAlD
Naloxone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.00119	CcSEcCtD
Naloxone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00119	CcSEcCtD
Naloxone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.00119	CcSEcCtD
Naloxone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00118	CcSEcCtD
Naloxone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000172	0.00118	CcSEcCtD
Naloxone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00117	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.00116	CcSEcCtD
Naloxone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.0011	CcSEcCtD
Naloxone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.00109	CcSEcCtD
Naloxone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.00109	CcSEcCtD
Naloxone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000159	0.00109	CcSEcCtD
Naloxone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.00108	CcSEcCtD
Naloxone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000158	0.00108	CcSEcCtD
Naloxone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00105	CcSEcCtD
Naloxone—Pain—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00104	CcSEcCtD
Naloxone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.00101	CcSEcCtD
Naloxone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.001	CcSEcCtD
Naloxone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000968	CcSEcCtD
Naloxone—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000959	CcSEcCtD
Naloxone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000958	CcSEcCtD
Naloxone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000958	CcSEcCtD
Naloxone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000887	CcSEcCtD
Naloxone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000887	CcSEcCtD
Naloxone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00087	CcSEcCtD
Naloxone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000829	CcSEcCtD
Naloxone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000805	CcSEcCtD
Naloxone—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000771	CcSEcCtD
Naloxone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000767	CcSEcCtD
Naloxone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000105	0.00072	CcSEcCtD
Naloxone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000713	CcSEcCtD
Naloxone—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000666	CcSEcCtD
Naloxone—ABCB1—cerebellum—peripheral nervous system neoplasm	7.86e-05	0.00522	CbGeAlD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.63e-05	0.000542	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	6.51e-05	0.000532	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	6.47e-05	0.000529	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	6.47e-05	0.000529	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	6.47e-05	0.000529	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	6.45e-05	0.000527	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	6.44e-05	0.000526	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—AKT1—peripheral nervous system neoplasm	6.41e-05	0.000524	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—NRAS—peripheral nervous system neoplasm	6.36e-05	0.00052	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.33e-05	0.000517	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—HRAS—peripheral nervous system neoplasm	6.32e-05	0.000517	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	6.32e-05	0.000516	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.31e-05	0.000516	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.31e-05	0.000515	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.29e-05	0.000514	CbGpPWpGaD
Naloxone—CREB1—Immune System—IFNB1—peripheral nervous system neoplasm	6.24e-05	0.00051	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	6.22e-05	0.000508	CbGpPWpGaD
Naloxone—CREB1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.19e-05	0.000506	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.15e-05	0.000502	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.09e-05	0.000498	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.07e-05	0.000496	CbGpPWpGaD
Naloxone—TLR4—Immune System—NRAS—peripheral nervous system neoplasm	6.05e-05	0.000495	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	6.05e-05	0.000494	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—PTPN11—peripheral nervous system neoplasm	6.03e-05	0.000493	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	6.03e-05	0.000493	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—AKT1—peripheral nervous system neoplasm	6.03e-05	0.000493	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	6.03e-05	0.000493	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	5.98e-05	0.000488	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	5.92e-05	0.000484	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	5.9e-05	0.000482	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.89e-05	0.000482	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	5.85e-05	0.000478	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.82e-05	0.000476	CbGpPWpGaD
Naloxone—CREB1—Disease—SLC2A1—peripheral nervous system neoplasm	5.8e-05	0.000474	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.8e-05	0.000474	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	5.79e-05	0.000473	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—NRAS—peripheral nervous system neoplasm	5.76e-05	0.00047	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.67e-05	0.000464	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—AKT1—peripheral nervous system neoplasm	5.58e-05	0.000456	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.53e-05	0.000452	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.53e-05	0.000452	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.52e-05	0.000451	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.51e-05	0.00045	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.47e-05	0.000447	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.45e-05	0.000445	CbGpPWpGaD
Naloxone—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.44e-05	0.000445	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	5.4e-05	0.000441	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.36e-05	0.000438	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	5.34e-05	0.000437	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.33e-05	0.000435	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	5.31e-05	0.000434	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.22e-05	0.000427	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.15e-05	0.000421	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.09e-05	0.000416	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	5.05e-05	0.000413	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	4.88e-05	0.000399	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.84e-05	0.000395	CbGpPWpGaD
Naloxone—CREB1—Immune System—HGF—peripheral nervous system neoplasm	4.82e-05	0.000394	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.77e-05	0.00039	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—ERBB2—peripheral nervous system neoplasm	4.77e-05	0.00039	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—HRAS—peripheral nervous system neoplasm	4.75e-05	0.000388	CbGpPWpGaD
Naloxone—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	4.71e-05	0.000385	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.67e-05	0.000382	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.66e-05	0.000381	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—HRAS—peripheral nervous system neoplasm	4.65e-05	0.00038	CbGpPWpGaD
Naloxone—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	4.6e-05	0.000376	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	4.58e-05	0.000374	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.55e-05	0.000372	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.52e-05	0.00037	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.5e-05	0.000368	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.49e-05	0.000367	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	4.46e-05	0.000365	CbGpPWpGaD
Naloxone—TLR4—Immune System—HRAS—peripheral nervous system neoplasm	4.43e-05	0.000362	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.4e-05	0.00036	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.37e-05	0.000357	CbGpPWpGaD
Naloxone—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	4.36e-05	0.000356	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.36e-05	0.000356	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.35e-05	0.000356	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.3e-05	0.000351	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—HRAS—peripheral nervous system neoplasm	4.21e-05	0.000344	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.13e-05	0.000338	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	4.12e-05	0.000337	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—AKT1—peripheral nervous system neoplasm	4.11e-05	0.000336	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—NRAS—peripheral nervous system neoplasm	4.11e-05	0.000336	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.1e-05	0.000335	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.09e-05	0.000334	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	4e-05	0.000327	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	3.96e-05	0.000323	CbGpPWpGaD
Naloxone—ALB—Metabolism—GNS—peripheral nervous system neoplasm	3.94e-05	0.000322	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.93e-05	0.000321	CbGpPWpGaD
Naloxone—TLR4—Immune System—AKT1—peripheral nervous system neoplasm	3.91e-05	0.00032	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	3.88e-05	0.000317	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.85e-05	0.000314	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.83e-05	0.000313	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.82e-05	0.000312	CbGpPWpGaD
Naloxone—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	3.81e-05	0.000312	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.81e-05	0.000311	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	3.79e-05	0.00031	CbGpPWpGaD
Naloxone—ALB—Metabolism—NME1—peripheral nervous system neoplasm	3.77e-05	0.000308	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.74e-05	0.000306	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.73e-05	0.000305	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.72e-05	0.000304	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	3.65e-05	0.000299	CbGpPWpGaD
Naloxone—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	3.63e-05	0.000297	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.63e-05	0.000297	CbGpPWpGaD
Naloxone—ALB—Metabolism—COX2—peripheral nervous system neoplasm	3.63e-05	0.000297	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—NRAS—peripheral nervous system neoplasm	3.63e-05	0.000296	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.6e-05	0.000294	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.56e-05	0.000291	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.55e-05	0.00029	CbGpPWpGaD
Naloxone—CREB1—Immune System—PTPN11—peripheral nervous system neoplasm	3.51e-05	0.000287	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	3.48e-05	0.000285	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	3.45e-05	0.000282	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.36e-05	0.000275	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	3.31e-05	0.00027	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.3e-05	0.00027	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.27e-05	0.000267	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.27e-05	0.000267	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.26e-05	0.000266	CbGpPWpGaD
Naloxone—CREB1—Disease—PTPN11—peripheral nervous system neoplasm	3.24e-05	0.000265	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.24e-05	0.000265	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.23e-05	0.000264	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	3.18e-05	0.00026	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	3.16e-05	0.000259	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.11e-05	0.000255	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.11e-05	0.000254	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—HRAS—peripheral nervous system neoplasm	3e-05	0.000246	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.94e-05	0.00024	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.89e-05	0.000236	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.86e-05	0.000234	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.86e-05	0.000234	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.84e-05	0.000232	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.84e-05	0.000232	CbGpPWpGaD
Naloxone—CREB1—Immune System—ERBB2—peripheral nervous system neoplasm	2.78e-05	0.000227	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.76e-05	0.000226	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	2.66e-05	0.000218	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—HRAS—peripheral nervous system neoplasm	2.65e-05	0.000217	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.65e-05	0.000217	CbGpPWpGaD
Naloxone—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.65e-05	0.000217	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.63e-05	0.000215	CbGpPWpGaD
Naloxone—CREB1—Disease—ERBB2—peripheral nervous system neoplasm	2.56e-05	0.00021	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	2.55e-05	0.000208	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.45e-05	0.0002	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.41e-05	0.000197	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	2.4e-05	0.000196	CbGpPWpGaD
Naloxone—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	2.38e-05	0.000195	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—AKT1—peripheral nervous system neoplasm	2.34e-05	0.000191	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.33e-05	0.000191	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.33e-05	0.00019	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.31e-05	0.000189	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.3e-05	0.000188	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.27e-05	0.000186	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.26e-05	0.000185	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	2.25e-05	0.000184	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.14e-05	0.000175	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.12e-05	0.000174	CbGpPWpGaD
Naloxone—CREB1—Immune System—NRAS—peripheral nervous system neoplasm	2.11e-05	0.000173	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	2.09e-05	0.000171	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.04e-05	0.000166	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	2.03e-05	0.000166	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.02e-05	0.000165	CbGpPWpGaD
Naloxone—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	2.01e-05	0.000165	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2e-05	0.000163	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.99e-05	0.000162	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.97e-05	0.000161	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.96e-05	0.00016	CbGpPWpGaD
Naloxone—CREB1—Disease—NRAS—peripheral nervous system neoplasm	1.95e-05	0.000159	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.93e-05	0.000158	CbGpPWpGaD
Naloxone—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.92e-05	0.000157	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	1.91e-05	0.000156	CbGpPWpGaD
Naloxone—ALB—Metabolism—TH—peripheral nervous system neoplasm	1.89e-05	0.000155	CbGpPWpGaD
Naloxone—CREB1—Disease—MYC—peripheral nervous system neoplasm	1.82e-05	0.000148	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.8e-05	0.000147	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.79e-05	0.000146	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.77e-05	0.000144	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.71e-05	0.00014	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.69e-05	0.000138	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.69e-05	0.000138	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.68e-05	0.000138	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.68e-05	0.000137	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.66e-05	0.000136	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.64e-05	0.000134	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.63e-05	0.000133	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.62e-05	0.000133	CbGpPWpGaD
Naloxone—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	1.59e-05	0.00013	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.57e-05	0.000128	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	1.56e-05	0.000127	CbGpPWpGaD
Naloxone—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	1.55e-05	0.000126	CbGpPWpGaD
Naloxone—CREB1—Immune System—HRAS—peripheral nervous system neoplasm	1.55e-05	0.000126	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	1.53e-05	0.000125	CbGpPWpGaD
Naloxone—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	1.52e-05	0.000124	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.49e-05	0.000122	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.49e-05	0.000122	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.49e-05	0.000122	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.48e-05	0.000121	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.44e-05	0.000117	CbGpPWpGaD
Naloxone—CREB1—Disease—HRAS—peripheral nervous system neoplasm	1.43e-05	0.000117	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.42e-05	0.000116	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.37e-05	0.000112	CbGpPWpGaD
Naloxone—CREB1—Immune System—AKT1—peripheral nervous system neoplasm	1.36e-05	0.000112	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.36e-05	0.000111	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	1.35e-05	0.000111	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.33e-05	0.000108	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.31e-05	0.000107	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.29e-05	0.000105	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—MYC—peripheral nervous system neoplasm	1.28e-05	0.000105	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.27e-05	0.000104	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.27e-05	0.000104	CbGpPWpGaD
Naloxone—CREB1—Disease—AKT1—peripheral nervous system neoplasm	1.26e-05	0.000103	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.25e-05	0.000102	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	1.22e-05	9.96e-05	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.22e-05	9.93e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.2e-05	9.84e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.19e-05	9.76e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.18e-05	9.61e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	1.17e-05	9.53e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.11e-05	9.09e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.1e-05	9.02e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.09e-05	8.89e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.07e-05	8.72e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.04e-05	8.54e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.04e-05	8.51e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.04e-05	8.48e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	1.03e-05	8.41e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.02e-05	8.36e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.01e-05	8.25e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.99e-06	8.17e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.96e-06	8.14e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.4e-06	7.68e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.13e-06	7.46e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.95e-06	7.31e-05	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—AKT1—peripheral nervous system neoplasm	8.89e-06	7.26e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.82e-06	7.21e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.8e-06	7.19e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.73e-06	7.14e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	8.54e-06	6.98e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	8.35e-06	6.82e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.33e-06	6.81e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	8.19e-06	6.69e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.72e-06	6.31e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.71e-06	6.3e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.38e-06	6.03e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.84e-06	5.59e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.55e-06	5.35e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.52e-06	5.33e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.78e-06	4.72e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	4.2e-06	3.43e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	4.17e-06	3.41e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	3.66e-06	2.99e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.25e-06	1.84e-05	CbGpPWpGaD
